132 related articles for article (PubMed ID: 37224970)
1. RNA analysis of tape strips to rule out melanoma in lesions clinically assessed as cutaneous malignant melanoma: A diagnostic study.
Heerfordt IM; Philipsen PA; Andersen JD; Langhans L; Schmidt G; Morling N; Wulf HC
J Am Acad Dermatol; 2023 Sep; 89(3):537-543. PubMed ID: 37224970
[TBL] [Abstract][Full Text] [Related]
2. Detection of cutaneous malignant melanoma using RNA sampled by tape strips: A study protocol.
Heerfordt IM; Andersen JD; Philipsen PA; Langhans L; Tvedebrink T; Schmidt G; Poulsen T; Lerche CM; Morling N; Wulf HC
PLoS One; 2022; 17(9):e0274413. PubMed ID: 36129945
[TBL] [Abstract][Full Text] [Related]
3. PRAME expression by immunohistochemistry and reverse transcription quantitative PCR in conjunctival melanocytic lesions-a comprehensive clinicopathologic study of 202 cases and correlation of cytogenetics with PRAME expression in challenging conjunctival melanocytic lesions.
Mudhar HS; Milman T; Stevenson S; Watson M; Kim J; Magan T; Salvi SM; Harley U; Lally SE; Shields CL
Hum Pathol; 2023 Apr; 134():1-18. PubMed ID: 36804828
[TBL] [Abstract][Full Text] [Related]
4. Associations of 9p21 variants with cutaneous malignant melanoma, nevi, and pigmentation phenotypes in melanoma-prone families with and without CDKN2A mutations.
Yang XR; Liang X; Pfeiffer RM; Wheeler W; Maeder D; Burdette L; Yeager M; Chanock S; Tucker MA; Goldstein AM
Fam Cancer; 2010 Dec; 9(4):625-33. PubMed ID: 20574843
[TBL] [Abstract][Full Text] [Related]
5. Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations.
Goldstein AM; Struewing JP; Chidambaram A; Fraser MC; Tucker MA
J Natl Cancer Inst; 2000 Jun; 92(12):1006-10. PubMed ID: 10861313
[TBL] [Abstract][Full Text] [Related]
6. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements.
Chandler WM; Rowe LR; Florell SR; Jahromi MS; Schiffman JD; South ST
Arch Pathol Lab Med; 2012 Aug; 136(8):947-55. PubMed ID: 22849744
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive genomic detection of melanoma.
Wachsman W; Morhenn V; Palmer T; Walls L; Hata T; Zalla J; Scheinberg R; Sofen H; Mraz S; Gross K; Rabinovitz H; Polsky D; Chang S
Br J Dermatol; 2011 Apr; 164(4):797-806. PubMed ID: 21294715
[TBL] [Abstract][Full Text] [Related]
9. Gene Expression Analysis Differentiates Melanomas from Spitz Nevi.
Jansen B; Hansen D; Moy R; Hanhan M; Yao Z
J Drugs Dermatol; 2018 May; 17(5):574-576. PubMed ID: 29742191
[TBL] [Abstract][Full Text] [Related]
10. Potential diagnostic utility of PRAME and p16 immunohistochemistry in melanocytic nevi and malignant melanoma.
Bahmad HF; Oh KS; Alexis J
J Cutan Pathol; 2023 Aug; 50(8):763-772. PubMed ID: 37114299
[TBL] [Abstract][Full Text] [Related]
11. Age at diagnosis and transmission of invasive melanoma in 23 families with cutaneous malignant melanoma/dysplastic nevi.
Goldstein AM; Fraser MC; Clark WH; Tucker MA
J Natl Cancer Inst; 1994 Sep; 86(18):1385-90. PubMed ID: 8072031
[TBL] [Abstract][Full Text] [Related]
12. Assessing Skin Cancer Using Epidermal Genetic Information Retrieved by Adhesive Patch Skin Surface Sampling.
Lee N; Scope A; Rabinovitz H
Dermatol Clin; 2017 Oct; 35(4):521-524. PubMed ID: 28886808
[TBL] [Abstract][Full Text] [Related]
13. Translation of a circulating miRNA signature of melanoma into a solid tissue assay to improve diagnostic accuracy and precision.
Laar RV; King S; McCoy R; Saad M; Fereday S; Winship I; Uzzell C; Landgren A
Biomark Med; 2021 Sep; 15(13):1111-1122. PubMed ID: 34184547
[No Abstract] [Full Text] [Related]
14. Detection of cutaneous malignant melanoma by tape stripping of pigmented skin lesions - A systematic review.
Thomsen IMN; Heerfordt IM; Karmisholt KE; Mogensen M
Skin Res Technol; 2023 Mar; 29(3):e13286. PubMed ID: 36973976
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a noninvasive 2-gene molecular assay for cutaneous melanoma.
Gerami P; Yao Z; Polsky D; Jansen B; Busam K; Ho J; Martini M; Ferris LK
J Am Acad Dermatol; 2017 Jan; 76(1):114-120.e2. PubMed ID: 27707590
[TBL] [Abstract][Full Text] [Related]
16. Histopathology-guided mass spectrometry differentiates benign nevi from malignant melanoma.
Lazova R; Smoot K; Anderson H; Powell MJ; Rosenberg AS; Rongioletti F; Pilloni L; D'Hallewin S; Gueorguieva R; Tantcheva-Poór I; Obadofin O; Camacho C; Hsi A; Kluger HH; Fadare O; Seeley EH
J Cutan Pathol; 2020 Mar; 47(3):226-240. PubMed ID: 31697431
[TBL] [Abstract][Full Text] [Related]
17. Truncating mutations of TP53AIP1 gene predispose to cutaneous melanoma.
Benfodda M; Gazal S; Descamps V; Basset-Seguin N; Deschamps L; Thomas L; Lebbe C; Saiag P; Zanetti R; Sacchetto L; Chiorino G; Scatolini M; Grandchamp B; Bensussan A; Soufir N
Genes Chromosomes Cancer; 2018 Jun; 57(6):294-303. PubMed ID: 29359367
[TBL] [Abstract][Full Text] [Related]
18. Linkage of cutaneous malignant melanoma/dysplastic nevi to chromosome 9p, and evidence for genetic heterogeneity.
Goldstein AM; Dracopoli NC; Engelstein M; Fraser MC; Clark WH; Tucker MA
Am J Hum Genet; 1994 Mar; 54(3):489-96. PubMed ID: 8116618
[TBL] [Abstract][Full Text] [Related]
19. [Fluorescence in-situ hybridization as a diagnostic tool for cutaneous melanoma].
Su J; Liu J; Zheng J; You J; Ma X; Zhang Y; Zhang J; Liao S
Zhonghua Bing Li Xue Za Zhi; 2015 Jan; 44(1):37-41. PubMed ID: 25765029
[TBL] [Abstract][Full Text] [Related]
20. [Dermoscopy--a glimpse into the skin].
Wolf O; Shalom A
Harefuah; 2010 Aug; 149(8):519-23, 550. PubMed ID: 21341432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
